Effects of the combination metformin and iSGLT-2 in clinical use
AbstractThe research is devoted to the study of the effects of a combination of drugs metformin and iSGLT-2 on the treatment of type 2 diabetes. Initial combination treatment with an iSGLT2 inhibitor and metformin shows high efficacy, results in a clinically meaningful and statistically significant improvement in glycemic control and weight loss.
Keywords: diabetes, iSGLT-2, chronic kidney disease, glycated hemoglobin, body mass index Funding.
Funding. The study had no sponsor support.
Conflict of interests. The authors declare no conflict of interests.
For citation: Makarshina D.A., Zhuravel V.V., Demidova T.Yu., Titova V.V. Effects of the combination metformin and iSGLT-2 in clinical use. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (4): 97–8. DOI: https://doi.org/10.33029/2304-9529-2020-9-4-97-98 (in Russian)